Is This Stock-Split Stock a Buy For 2023?

10:00am, Saturday, 26'th Nov 2022
Don't buy this company's shares for its recent stock split.

Dexcom Leads 5 Stocks Near Buy Points

07:45am, Friday, 25'th Nov 2022
Dexcom and other top stocks to watch this week combine strong technicals with generally solid fundamentals. The post Dexcom Leads 5 Stocks Near Buy Points appeared first on Investor's Business Daily.
After launching three new products and posting a second quarter of rising EPS growth, medical devices leader Merit Medical Systems is probing a new buy point. The post Medical Devices Stock Pumps Up B
Don't let the current market keep you from putting spare cash to work in great companies.
Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023.
When searching for growth stocks to buy, investors should first ascertain what growth means to them. It varies from person to person.
Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.
Regardless of what the market does next, these top stocks have a much longer growth trajectory ahead.
These widely held stock-split stocks put the bear market in its place by respectively gaining 27% and 50% in October.

2 Growth Stocks That Are Soaring: Are They Buys?

08:45am, Saturday, 05'th Nov 2022
Both companies are still down over the past year, but they were on fire in October.

Is It Too Late to Buy DexCom Stock?

08:45am, Friday, 04'th Nov 2022
The shares have been surging after the medical device specialist released its latest earnings report.

Is DexCom a Good Healthcare Stock to Buy Now?

05:31am, Wednesday, 02'nd Nov 2022
After rising about 50% in October, investors want to know if this stock still has any fuel in the tank.

7 Stocks Billionaires are Buying Now

06:46am, Tuesday, 01'st Nov 2022
It isn't easy to figure out which stocks billionaires are buying right now. With sky-high inflation, fears of recession, weak economic growth, Russia's invasion of Ukraine, and a weaker consumer, the
keep them on track to be the S&P 500's SPX, -0.55% best October performer with a month-to-date gain of 50.6%. The rally comes as maker of glucose monitoring systems reported last week third-quarter re

DexCom Stock: Bull vs. Bear

09:02am, Sunday, 30'th Oct 2022
The diabetes care technology leader has a huge opportunity. But its valuation could be an issue.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE